(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 4. 12.5 dpc XY Fgf9 null gonads express markers of ovarian
development. In situ hybridization using markers of ovarian fate
Bmp2 (A,C,E,G) and follistatin (B,D,F,H) on 12.5 dpc XX (A-D) and XY
(E-H) gonads of either Fgf9+/ (A,B,E,F) or
Fgf9/ (C,D,G,H) genotypes. All XX gonads
express Bmp2 and follistatin normally (A-D). XY
Fgf9+/ samples do not express either of these
ovarian markers (E,F). At 12.5 dpc, XY
Fgf9/ gonads express both Bmp2 and
follistatin (G,H) in a pattern similar to XX gonads. Sections of
14.5 dpc XX and XY gonads containing germ cells immunostained for PECAM
(green) and phosphorylated
H2AX (red) (I-K). Virtually all XX
Fgf9+/ germ cells are positive for phosphorylated
H2AX staining, as expected (I), whereas XY Fgf9+/
germ cells are not (J). Forty-seven percent of the germ cells that survive to
this stage in XY Fgf9/ gonads are positive for
phosphorylated
H2AX (arrowhead in K), but some are not (arrow in K).
Figures representative of three independent experiments of n
5
(A-H) each and n=5 (I-K) each. Scale bar: 250 µm in A-H; 25 µm
in I,K.